Related Experiment Video
Updated: Sep 22, 2025

A High-throughput Method for Measurement of Glomerular Filtration Rate in Conscious Mice
Published on: May 10, 2013
A Study of Estimated Glomerular Filtration Rate in Patients Undergoing Diagnostic or Interventional Coronary Contrast
Mohammed Shoeb A Khan1, K Vinod Kumar1, R Anil Kumar2
1Department of Nephrology, Aster Medcity, Kochi, Kerala, India.
Insights
Contrast-induced acute kidney injury (CI-AKI) occurred in 23.4% of chronic kidney disease (CKD) patients undergoing coronary procedures. However, CI-AKI was self-limiting and did not significantly impact estimated glomerular filtration rate (eGFR) at 3 months.
Area of Science:
- Nephrology
- Cardiology
- Radiology
Background:
- Angiographic procedures are underutilized in chronic kidney disease (CKD) patients with acute coronary syndromes due to the risk of contrast-induced acute kidney injury (CI-AKI).
- Assessing the impact of CI-AKI on kidney function is crucial for managing CKD patients undergoing cardiovascular interventions.
Purpose of the Study:
- To evaluate the change in estimated glomerular filtration rate (eGFR) over 3 months in CKD patients following coronary procedures.
- To determine the incidence and effects of CI-AKI in this high-risk population.
Main Methods:
- An observational study included 282 CKD patients (eGFR <60 mL/min/1.73 m²).
- eGFR was calculated using the CKD-EPI equation pre-procedure and at 24, 48, 72 hours, and 30, 90 days post-procedure.
- CI-AKI prophylaxis followed KDIGO guidelines.
Main Results:
- CI-AKI developed in 66 (23.4%) patients, with incidence increasing with CKD severity.
- Mean contrast volume was 55.17 mL for coronary angiogram and 156.94 mL for percutaneous transluminal coronary angioplasty.
- No significant change in eGFR was observed at 1 and 3 months post-procedure, even in patients who developed CI-AKI.
Conclusions:
- CI-AKI in CKD patients undergoing coronary procedures is generally self-limiting.
- The condition does not appear to have major detrimental effects on long-term eGFR at 3 months post-contrast exposure.
Introduction:
Angiographic procedures are underused in patients with chronic kidney disease (CKD), who present with acute coronary syndromes, due to risk of contrast-induced acute kidney injury (CI-AKI). In this study, we assessed the change in estimated glomerular filtration rate (eGFR) over 3 months following coronary procedures in CKD patients.
Methods:
This observational study was done from July 2017 to January 2019 in patients undergoing elective coronary procedures with an eGFR <60 mL/min/1.73 m2. CKD-EPI equation was used to calculate eGFR pre and post coronary procedure at 24, 48, and 72 hours as well as 30, 90 days. AKI was diagnosed and patients were given prophylaxis for CI-AKI as per KDIGO recommendation (intravenous normal saline and oral N-acetyl cysteine).
Results:
Patients studied were 282 (225 males, 57 females) of which 68.1% were diabetics. Mean eGFR was 42.91 ± 10.51 mL/min/1.73 m2 and mean hemoglobin was 12.08 ± 1.51 gm/dL. Coronary angiogram (CAG) was done in 174; percutaneous transluminal coronary angioplasty (PTCA) was done in 108. Mean contrast volume in CAG was 55.17 ± 34.45 mL and in PTCA was 156.94±±47.99 mL. CI-AKI was seen in 66 (23.4%) patients. The incidence of CI-AKI increased with severity of underlying CKD. The variability of eGFR at 1 and 3 months after coronary procedures showed no significant change from baseline, even in the patients who developed CI-AKI.
Conclusions:
CI-AKI is self-limiting and has no major detrimental effects on eGFR at 1 and 3 months after contrast exposure.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Imaging Studies VII: Vascular Imaging
Renal Clearance
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
Imaging Studies III: Computed Tomography
Imaging Studies for Cardiovascular System V: CT
Renal Drug Excretion: Glomerular Filtration
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles....

